Modest weight gain is associated with sympathetic neural activation in nonobese humans (Q44926120)

7 December 2017

title

Modest weight gain is associated with sympathetic neural activation in nonobese humans (English)

1 reference

7 December 2017

1 reference

Christopher L Gentile

1 reference

7 December 2017

Jeb S Orr

1 reference

7 December 2017

Brenda M Davy

1 reference

7 December 2017

Kevin P Davy

1 reference

7 December 2017

publication date

11 January 2007

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

7 December 2017

published in

1 reference

7 December 2017

volume

292

1 reference

7 December 2017

1 reference

7 December 2017

page(s)

R1834-8

1 reference

Subcutaneous obesity is not associated with sympathetic neural activation

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Vascular adrenergic responsiveness is inversely related to tonic activity of sympathetic vasoconstrictor nerves in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Adverse mortality effect of central sympathetic inhibition with sustained‐release moxonidine in patients with heart failure (MOXCON)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Obesity and hypertension: two epidemics or one?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

How to assess sympathetic activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Sympathetic nerve activity and insulin in obese normotensive and hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

The kidney, hypertension, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Obesity-associated hypertension and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Disparity of autonomic control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Adverse consequences of high sympathetic nervous activity in the failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Changes in Energy Expenditure Resulting from Altered Body Weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Weight gain-induced blood pressure elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Differential control of sympathetic outflow

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Noradrenaline turnover during under- and over-eating in normal weight subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Muscle sympathetic nerve activity in response to glucose ingestion. Impact of plasma insulin and body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Gender differences in the dietary lard-induced increase in blood pressure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Aging accelerates dietary lard-induced increase in blood pressure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Possible genetic influence on the strength of human muscle nerve sympathetic activity at rest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Peripheral sympathetic neural activity in conscious humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00876.2006

10.1152/AJPREGU.00876.2006

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference